KFSHRC Detects 267 Fetal Genetic Disorders Through Prenatal Care
King Faisal Specialist Hospital & Research Centre (KFSHRC) is enhancing prenatal care through innovation and precision medicine. By testing more than 300 genes, KFSHRC has provided early insights to 1,104 pregnant women, preventing 267 genetic disorders and saving the Saudi healthcare system SAR360 million annually.
KFSHRC’s Preventive Fetal Screening Program identifies genetic risks and ensures targeted care during critical pregnancy stages. Paired with technologies like Next-Generation Sequencing (NGS) and Non-Invasive Prenatal Testing (NIPT), these advancements enhance the precision and safety of prenatal diagnostics, benefiting 1,500 families annually. The Program has expanded its capacity to detect more than 500 additional genetic diseases, equipping families with early insights, reducing the birth of new-borns with severe genetic diseases, and improving overall offspring outcomes and well-being.
KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.
Related Topics :
Minister of Health Honors KFSHRC with 2025 Model of Care Innovation Award
KFSHRC Achieves World’s First Robotic-Assisted Artificial Heart Pump Implantation
Saudi Arabia Conducts World’s First Robotic-Assisted Artificial Heart Pump Implantation
Discover Aramco’s First Gas Storage Facility in Saudi Arabia